Project information
EATRIS-CZ: Czech National Node to the European Infrastructure for Translational Medicine
(EATRIS-CZ)
- Project Identification
- LM2023053
- Project Period
- 1/2023 - 12/2026
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Large Infrastructures for Research, Development and Innovation
- MU Faculty or unit
- Central European Institute of Technology
- Cooperating Organization
-
Institute of Microbiology of the ASCR, v. v. i.
Institute of Experimental Medicine of the ASCR, v. v. i.
Institute of Nuclear Physics
Institute of Macromolecular Chemistry of the ASCR, v. v. i.
Institute of Organic Chemistry and Biochemistry of the ASCR, v. v. i.
Charles University
Palacký University, Olomouc
- Responsible person doc. MUDr. Marián Hajdúch, Ph.D.
St. Anne's University Hospital Brno
EATRIS-CZ is coordinated by Palacky University in Olomouc. It is the national hub of the European Infrastructure for Translational Medicine (EATRIS), which includes more than 80 research organizations from across Europe. EATRIS-CZ provides excellent research infrastructure and expertise throughout the translation allotment chain. Through 5 interconnected platforms, it enables to achieve in the development of drugs and diagnostics up to the levels of "first administration in humans" or clinical verification (proof-of-concept). EATRIS-CZ offers multidisciplinary developments, including key technologies, services, patient cohorts and interactions with key opinion holders.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Publications
Total number of publications: 10
2024
-
Curcumin: A Potential Weapon in the Prevention and Treatment of Head and Neck Cancer
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, year: 2024, DOI
-
Cyanine dyes in the mitochondria-targeting photodynamic and photothermal therapy
COMMUNICATIONS CHEMISTRY, year: 2024, volume: 7, edition: 1, DOI
-
In-cell NMR suggests that DNA i-motif levels are strongly depleted in living human cells
Nature Communications, year: 2024, volume: 15, edition: 1, DOI
-
Interictal stereo-electroencephalography features below 45 Hz are sufficient for correct localization of the epileptogenic zone and postsurgical outcome prediction
Epilepsia, year: 2024, DOI
-
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
Nature Scientific Reports, year: 2024, volume: 14, edition: 1, DOI
-
Iron chelators as mitophagy agents: Potential and limitations
BIOMEDICINE & PHARMACOTHERAPY, year: 2024, volume: 179, edition: October 2024, DOI
-
Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study
Hematological Oncology, year: 2024, volume: 42, edition: 3, DOI
-
Timing matters for accurate identification of the epileptogenic zone
Clinical Neurophysiology, year: 2024, volume: 161, edition: May 2024, DOI
2023
-
A thermosensitive gel matrix for bioreactor-assisted in-cell NMR of nucleic acids and proteins
Journal of biomolecular NMR, year: 2023, volume: 77, edition: 5-6, DOI
-
TET protein inhibitors: Potential and limitations
Biomedicine & Pharmacotherapy, year: 2023, volume: 166, edition: October 2023, DOI